Key Highlights
- A $2 billion federal quantum computing initiative will distribute grants to nine companies, with the government obtaining equity positions in each firm.
- Despite being the leading publicly-traded pure-play quantum computing company, IonQ was excluded from the grant recipients list.
- Competitors including D-Wave Quantum (QBTS), Rigetti Computing (RGTI), and Infleqtion (INFQ) secured $100 million each, while IBM received $1 billion.
- IONQ shares climbed approximately 9.5% Thursday morning, even as analysts project continued losses for multiple years ahead.
- According to MarketBeat data, Wall Street maintains a “Moderate Buy” rating on IonQ with a consensus price target of $68.63.
The company’s most recent quarterly results revealed revenue of $64.67 million — representing a year-over-year surge of 754.7% — yet IonQ fell short of earnings projections, recording a per-share loss of $0.34 versus analyst expectations of a $0.26 loss.
Opening Thursday at approximately $52.53, IONQ shares climbed nearly 9.5% despite the company’s exclusion from a significant federal funding program. This counterintuitive market reaction exemplifies the unpredictable nature of quantum computing equities — simultaneously fascinating and challenging to forecast.
According to an exclusive report from The Wall Street Journal, the Trump Administration’s initiative will allocate $2 billion across nine quantum computing enterprises. Additionally, the federal government will acquire equity positions in all participating companies, creating direct financial alignment with these firms’ future performance.
IBM dominates the allocation with $1 billion. Globalfoundries secured $375 million. D-Wave, Rigetti, and Infleqtion each obtained $100 million. The balance goes to several private entities, including a firm with partial ownership by 1789 Capital, backed by Donald Trump Jr.
IonQ received nothing.
Implications for IonQ’s Competitors
The government’s decision to acquire equity stakes extends beyond mere capital injection — it establishes a vested federal interest in these companies’ long-term success. This represents a meaningful competitive advantage that IonQ’s rivals now possess.
D-Wave (QBTS) skyrocketed over 24%, Rigetti (RGTI) soared nearly 25%, and Infleqtion (INFQ) advanced more than 30% following the announcement. IBM shares increased close to 8%.
For market participants, the puzzle remains: why did IonQ advance despite its exclusion? One plausible explanation: the government’s substantial commitment validates quantum computing as a sector, creating a rising tide that elevates all participants — including those who didn’t secure funding.
Analyst Perspectives on IonQ
Currently, ten analysts maintain Buy recommendations on IONQ. Six rate it as Hold, while one has issued a Sell rating. The overall consensus stands at “Moderate Buy” with a $68.63 price objective.
However, Morgan Stanley established a $48.50 target, and DA Davidson reduced its price forecast from $55 to $35 with a neutral stance in February. Skepticism persists among certain analysts.
The company maintains a market capitalization near $19.6 billion, demonstrates a beta of 3.05, and trades within a 52-week range spanning $25.89 to $84.64. The 50-day moving average rests at $39.31.
Institutional activity has intensified. DNB Asset Management expanded its IonQ position by over 1,099% during Q4, accumulating 55,230 shares valued at approximately $2.48 million. Multiple additional funds have established positions.
Regarding insider transactions, Director William Teuber acquired 3,000 shares at $38.38 in late February. Overall, insiders divested 12,354 shares worth $504,428 throughout the previous quarter.
Analyst consensus for full-year earnings per share sits at -$1.99, indicating persistent losses for the foreseeable future.
